24 July 2024
Sanofi vs. Amgen: Successful first UPC revocation action and strict assessment of therapeutic antibodies patentability
25 July 2023
APIXABAN case in France: priority to the patentee
26 October 2020
PEMETREXED patent infringement in France: €28 million in damages for Eli Lilly (“France is back”?)